RECRUITING

Use of Hand-held Dynamometry to Obtain Objective Measures of Lower Extremity Force Production With Chronic Stroke

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study wants to know if using handheld dynamometry (HHD) to test leg strength in persons who have had a stroke, will reduce mistakes and give therapists better information to use for therapy. This study will collect normal values of leg muscle peak force production, cumulative peak force production, and sustained peak force production in patients with chronic stroke.

Official Title

Use of Hand-held Dynamometry to Obtain Objective Measures of Lower Extremity Rate of Peak Force Production, Cumulative Peak Force Production, and Sustained Peak Force Production Among Patients With Chronic Stroke

Quick Facts

Study Start:2023-06-05
Study Completion:2025-07-26
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05941962

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years or older
  2. * Stroke \> 3 months
  3. * Ability to follow two-step commands
  4. * Ability to assume all test positions and maintain for duration of testing (i.e. upright seated, prone, side lying, supine)
  1. * Lower extremity contractures preventing full passive range of motion (ROM)
  2. * Vital signs contraindicated for exercise (i.e. resting heart rate \> 100 bpm \< 50 bpm, resting systolic blood pressure \> 200 mmHg or \< 90 mmHg, resting diastolic blood pressure \> 110 mmHg, oxygen saturation \< 90%)
  3. * Symptoms contraindicated for testing (i.e. shortness of breath, angina, dizziness, severe headache, sudden onset of numbness or weakness, painful calf suggestive of deep vein thrombosis)
  4. * Active infection and/or injury at location of testing site
  5. * Other diagnosed co-morbidities that would impact physical participation

Contacts and Locations

Study Contact

Cathey Norton
CONTACT
615-460-6715
cathey.norton@belmont.edu

Study Locations (Sites)

Vanderbilt University Medical Center
Nashville, Tennessee, 37209-2069
United States

Collaborators and Investigators

Sponsor: Vanderbilt University Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-05
Study Completion Date2025-07-26

Study Record Updates

Study Start Date2023-06-05
Study Completion Date2025-07-26

Terms related to this study

Additional Relevant MeSH Terms

  • Chronic Stroke
  • Weakness, Muscle